Valuation Edwards Lifesciences Corporation
Stocks
EW
US28176E1082
Advanced Medical Equipment & Technology
|
Market Closed -
NYSE
01:30:03 05/09/2026 am IST
|
5-day change | 1st Jan Change | ||
| 89.90 USD | +0.13% |
|
-0.34% | +5.45% |
Company Valuation: Edwards Lifesciences Corporation
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 80,883 | 46,128 | 46,246 | 43,663 | 49,471 | 51,818 | - | - |
| Change | - | -42.97% | 0.25% | -5.58% | 13.3% | 4.75% | - | - |
| Enterprise Value (EV) 1 | 80,616 | 45,956 | 45,198 | 40,285 | 45,843 | 48,187 | 46,624 | 44,808 |
| Change | - | -42.99% | -1.65% | -10.87% | 13.8% | 5.12% | -3.25% | -3.89% |
| P/E | 54.4x | 30.6x | 33.2x | 10.6x | 46.6x | 35.5x | 27.2x | 24.2x |
| PBR | 13.9x | 7.82x | 6.99x | 4.36x | 4.79x | 4.88x | 4.25x | 3.94x |
| PEG | - | 12.14x | -5.79x | 0x | -0.6x | 0.9x | 0.9x | 1.9x |
| Capitalization / Revenue | 15.5x | 8.57x | 7.7x | 8.03x | 8.15x | 7.67x | 6.98x | 6.34x |
| EV / Revenue | 15.4x | 8.54x | 7.53x | 7.41x | 7.56x | 7.13x | 6.28x | 5.48x |
| EV / EBITDA | 46.6x | 23.7x | 24.1x | 24.1x | 25.5x | 22.5x | 19.6x | 16.7x |
| EV / EBIT | 50.6x | 25.6x | 26.1x | 26.6x | 27.9x | 24.5x | 21.1x | 18x |
| EV / FCF | 57.3x | 47.2x | 47.9x | 139x | 34.3x | 56.8x | 29x | 24.6x |
| FCF Yield | 1.74% | 2.12% | 2.09% | 0.72% | 2.91% | 1.76% | 3.45% | 4.06% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | 2.38 | 2.44 | 2.3 | 6.97 | 1.83 | 2.531 | 3.304 | 3.718 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 5,232 | 5,382 | 6,005 | 5,440 | 6,068 | 6,759 | 7,429 | 8,177 |
| EBITDA 1 | 1,729 | 1,936 | 1,879 | 1,670 | 1,800 | 2,137 | 2,384 | 2,687 |
| EBIT 1 | 1,594 | 1,796 | 1,734 | 1,514 | 1,644 | 1,971 | 2,212 | 2,484 |
| Net income 1 | 1,503 | 1,522 | 1,402 | 4,175 | 1,074 | 1,435 | 1,897 | 2,121 |
| Net Debt 1 | -267 | -172.7 | -1,048 | -3,378 | -3,628 | -3,631 | -5,195 | -7,011 |
| Reference price 2 | 129.55 | 74.61 | 76.25 | 74.03 | 85.25 | 89.90 | 89.90 | 89.90 |
| Nbr of stocks (in thousands) | 6,24,334 | 6,18,260 | 6,06,500 | 5,89,800 | 5,80,300 | 5,76,400 | - | - |
| Announcement Date | 26/01/22 | 31/01/23 | 06/02/24 | 11/02/25 | 10/02/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 35.52x | 7.13x | 22.55x | -.--% | 5.18TCr | ||
| 30.5x | 5.4x | 20.72x | 0.3% | 23TCr | ||
| 35.03x | 6.31x | 20.02x | 0.69% | 15TCr | ||
| 40.22x | 10.44x | 23.09x | -.--% | 13TCr | ||
| 17.84x | 3.65x | 11.85x | -.--% | 6.93TCr | ||
| 19.37x | 2.33x | 11.69x | 2.63% | 5.04TCr | ||
| 29.39x | 5.8x | 19.69x | 0.68% | 4.25TCr | ||
| 71.67x | 6.84x | 20.83x | -.--% | 4.02TCr | ||
| 44.12x | 7.18x | 25.33x | -.--% | 3.3TCr | ||
| 19.57x | 5.5x | 14.21x | 1.16% | 3.29TCr | ||
| Average | 34.32x | 6.06x | 19.00x | 0.55% | 8.23TCr | |
| Weighted average by Cap. | 33.47x | 6.30x | 19.66x | 0.45% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- EW Stock
- Valuation Edwards Lifesciences Corporation
Select your edition
All financial news and data tailored to specific country editions
















